Celaid Therapeutics Inc. Secures up to $19M Grant from the Japanese Agency for Medical Research and Development

Celaid Therapeutics secures up to approx. $19M non-dilutive grant funding from Japanese government. The grant funding will support the development of Celaid’s hematopoietic stem cell product for pediatric non-malignant diseases.